WARSAW, Ind., Oct. 10, 2012 /PRNewswire/ -- Zimmer, Inc., a global leader in musculoskeletal health, today celebrated 15 years of clinical history of its Trabecular MetalTechnology at its dedicated facility in Parsippany, New Jersey. Trabecular Metal Technology is a core platform technology for Zimmer, helping the Company restore mobility and alleviate pain for millions of people around the world.
"Trabecular Metal Technology is among the greatest innovations in orthopaedics in the last 15 years. No other porous metal material so closely resembles the structure, function and physiology of trabecular bone. That is why Trabecular Metal Technology continues to set the standard in the industry," said Jeff McCaulley, President, Zimmer Reconstructive. "Trabecular Metal Material features unmatched porosity, which helps living tissue and bone grow onto and into joint replacements and implants."
Since its introduction in 1997, Trabecular Metal Technology has been used in more than 800,000 surgeries worldwide. The technology has been featured in more than 240 clinical publications and countless surgeons have adopted it for use with their patients. Over the past 15 years, applications of Trabecular Metal Technology have grown steadily. Trabecular Metal Technology is now used in knee, hip and shoulder replacements, trauma applications, spine implants, dental implants and bone void fillers and augments used in oncology.
Zimmer's Parsippany Trabecular Metal Technology facility is 115,000 square feet, boasts 230 employees and runs 24/7. In addition to manufacturing, it hosts a Zimmer Institute training center, providing medical education and training to hundreds of surgeons and dental clinicians each year.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
SOURCE Zimmer, Inc.